| User's Publication |
|
20916
Kitayama S, Ikeda K, Sato W, Takeshita H, Kawakami S, Inoue S, Horie K.
Testis-expressed gene 11 inhibits cisplatin-induced DNA damage and contributes to chemoresistance in testicular germ cell tumor.
Sci Rep
2022
12(1):18423
PubMed ID: 36319719
DOI: 10.1038/s41598-022-21856-3
|
|
13072
Sakurai Y, Ichinoe M, Yoshida K, Nakazato Y, Saito S, Satoh M, Nakada N, Sanoyama I, Umezawa A, Numata Y, Shi-Xu J, Ichihara M, Takahashi M, Murakumo Y.
Inactivation of REV7 enhances chemosensitivity and overcomes acquired chemoresistance in testicular germ cell tumors.
Cancer Lett
2020
PubMed ID: 32553781
DOI: 10.1016/j.canlet.2020.06.001
|
|
11326
Abe T, Kohashi K, Takemoto J, Kinoshita F, Eto M, Oda Y.
Clinicopathological Significance and Antitumor Effect of MPHOSPH1 in Testicular Germ Cell Tumor.
J Cancer
2018
PubMed ID: 30519350
DOI: 10.7150/jca.25279
|
|
7130
Kita H, Okamoto K, Kushima R, Kawauchi A, Chano T.
Dimethyl sulfoxide induces chemotherapeutic resistance in the treatment of testicular embryonal carcinomas.
Oncol Lett
2015
10:661-666
PubMed ID: 26622550
DOI: 10.3892/ol.2015.3306
|
|
6384
Hidenori Kawashima Sakae Masaki Marie Kawamura
Induction of HLA‑A* 33‑restricted cytotoxic lymphocytes against renal cell carcinoma targeting galectin 9 and PINCH
Biomedical Reports
2014
2:809-812
PubMed ID: 25279150
DOI: 10.3892/br.2014.334
|
|
6390
Kawashima H, Obayashi A, Kawamura M, Masaki S, Tamada S, Iguchi T, Uchida J, Kuratsukuri K, Tanaka T, Nakatani T.
Galectin 9 and PINCH, novel immunotherapy targets of renal cell carcinoma: a rationale to find potential tumour antigens and the resulting cytotoxic T lymphocytes induced by the derived peptides.
BJU Int
2014
113(2):320-32
PubMed ID: 24895689
DOI: 10.1111/bju.12499
|
|
6395
Ando S, Matsuoka T, Kawai K, Sugita S, Joraku A, Kojima T, Suetomi T, Miyazaki J, Fujita J, Nishiyama H.
Expression of the oncoprotein gankyrin and phosphorylated retinoblastoma protein in human testis and testicular germ cell tumor.
Int J Urol
2014
21(10):992-8
PubMed ID: 24861729
DOI: 10.1111/iju.12484
|
|
6398
Nagano K, Yamashita T, Inoue M, Higashisaka K, Yoshioka Y, Abe Y, Mukai Y, Kamada H, Tsutsumi Y, Tsunoda S
Eph receptor A10 has a potential as a target for a prostate cancer therapy.
Biochem Biophys Res Commun
2014
450(1):545-9
PubMed ID: 24924629
DOI: 10.1016/j.bbrc.2014.06.007
|
|
15922
Fujitani N, Furukawa J, Araki K, Fujioka T, Takegawa Y, Piao J, Nishioka T, Tamura T, Nikaido T, Ito M, Nakamura Y, Shinohara Y.
Total cellular glycomics allows characterizing cells and streamlining the discovery process for cellular biomarkers
Proc Natl Acad Sci U S A
2013
110(6):2105-10
PubMed ID: 23345451
DOI: 10.1073/pnas.1214233110
|
|
6385
Ushida H, Chano T, Minami K, Kita H, Kawakami T, Okabe H, Okada Y, Okamoto K.
Therapeutic potential of SOX2 inhibition for embryonal carcinoma.
J Urol
2012
187(5):1876-81
PubMed ID: 22425046
DOI: 10.1016/j.juro.2011.12.058
|
|
6391
Fujitani N, Takegawa Y, Ishibashi Y, Araki K, Furukawa J, Mitsutake S, Igarashi Y, Ito M, Shinohara Y.
Qualitative and quantitative cellular glycomics of glycosphingolipids based on rhodococcal endoglycosylceramidase-assisted glycan cleavage, glycoblotting-assisted sample preparation, and matrix-assisted laser desorption ionization tandem time-of-flight mass spectrometry analysis.
J Biol Chem
2011
286(48):41669-79
PubMed ID: 21965662
DOI: 10.1074/jbc.M111.301796
|
|
6394
Behjati R, Kawai K, Inadome Y, Kano J, Akaza H, Noguchi M.
APAF-1 is related to an undifferentiated state in the testicular germ cell tumor pathway.
Cancer Sci
2011
102(1):267-74
PubMed ID: 20977544
DOI: 10.1111/j.1349-7006.2010.01750.x
|
|
6387
Minami K, Chano T, Kawakami T, Ushida H, Kushima R, Okabe H, Okada Y, Okamoto K.
DNMT3L is a novel marker and is essential for the growth of human embryonal carcinoma.
Clin Cancer Res
2010
16(10):2751-9
PubMed ID: 20460473
DOI: 10.1158/1078-0432.CCR-09-3338
|
|
6388
Ogino H, Nakayama R, Sakamoto H, Yoshida T, Sugimura T, Masutani M.
Analysis of poly(ADP-ribose) polymerase-1 (PARP1) gene alteration in human germ cell tumor cell lines.
Cancer Genet Cytogenet
2010
197(1):8-15
PubMed ID: 20113831
DOI: 10.1016/j.cancergencyto.2009.10.012
|
|
3374
Yanagisawa, Ayano, Endo, Chisato, Okawa, Katsuya, Shitara, Shingo, Kugoh, Hiroyuki, Kakitani, Makoto, Oshimura, Mitsuo, Tomizuka, Kazuma
Generation of chromosome-specific monoclonal antibodies using in vitro-differentiated transchromosomic mouse embryonic stem cells.
Stem Cells
2005
23:1479-88
PubMed ID: 16081665
DOI: 10.1634/stemcells.2004-0369
|
|
2888
Sekiguchi T, Iida H, Fukumura J, Nishimoto T
Human DDX3Y, the Y-encoded isoform of RNA helicase DDX3, rescues a hamster temperature-sensitive ET24 mutant cell line with a DDX3X mutation.
Exp Cell Res
2004
300:213-22
PubMed ID: 15383328
DOI: 10.1016/j.yexcr.2004.07.005
|
|
6397
Shirakawa T, Gotoh A, Zhang Z, Kao C, Chung LW, Gardner TA.
Development of human chorionic gonadotropin subunit-beta promoter-based toxic gene therapy for testicular cancer.
Urology
2004
63(3):613-8
PubMed ID: 15028478
DOI: 10.1016/j.urology.2003.09.054
|
|
6389
Iwashita S, Koyama K, Nakamura Y.
VNTR sequence on human chromosome 11p15 that affects transcriptional activity.
J Hum Genet
2001
46(12):717-21
PubMed ID: 11776385
DOI: 10.1007/s100380170006
|
|
6392
Nadano D, Aoki C, Yoshinaka T, Irie S, Sato TA.
Electrophoretic characterization of ribosomal subunits and proteins in apoptosis: specific downregulation of S11 in staurosporine-treated human breast carcinoma cells.
Biochemistry.
2001
40(50):15184-93
PubMed ID: 11735401
DOI: 10.1021/bi0108397
|
Back
Top
CELL BANK Website